Systematic in silico analysis of clinically tested drugs for reducing amyloid‐beta plaque accumulation in Alzheimer's disease

INTRODUCTION: Despite strong evidence linking amyloid beta (Aβ) to Alzheimer's disease, most clinical trials have shown no clinical efficacy for reasons that remain unclear. To understand why, we developed a quantitative systems pharmacology (QSP) model for seven therapeutics: aducanumab, crene...

Descripción completa

Detalles Bibliográficos
Autores principales: Madrasi, Kumpal, Das, Raibatak, Mohmmadabdul, Hafiz, Lin, Lin, Hyman, Bradley T., Lauffenburger, Douglas A., Albers, Mark W., Rissman, Robert A., Burke, John M., Apgar, Joshua F., Wille, Lucia, Gruenbaum, Lore, Hua, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478725/
https://www.ncbi.nlm.nih.gov/pubmed/33938131
http://dx.doi.org/10.1002/alz.12312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478725/
https://www.ncbi.nlm.nih.gov/pubmed/33938131
http://dx.doi.org/10.1002/alz.12312

Ejemplares similares